Temporary changes in STI & HIV testing & diagnoses across different phases of the COVID-19 pandemic, Chicago IL.

COVID- 19 HIV testing MSM (men having sex with men) STI testing transgender

Journal

Frontiers in reproductive health
ISSN: 2673-3153
Titre abrégé: Front Reprod Health
Pays: Switzerland
ID NLM: 9918230899006676

Informations de publication

Date de publication:
2023
Historique:
received: 17 10 2022
accepted: 17 04 2023
medline: 19 5 2023
pubmed: 19 5 2023
entrez: 19 5 2023
Statut: epublish

Résumé

While the U.S. has seen a sustained rise in STI cases over the past decade, the impact of the COVID-19 on STIs and HIV is unclear. To examine the short- and medium-term impacts of COVID-19 and HIV and STI testing and diagnosis, we compared pre-pandemic trends to three periods of the pandemic: early- pandemic, March-May 2020; mid-pandemic June 2020-May 2021; and late-pandemic, June 2021-May 2022. We compared average number of monthly tests and diagnoses, overall and by gender, as well as the monthly change (slope) in testing and diagnoses. We find that after decreases in average monthly STI and HIV testing and diagnoses during the early- and mid-pandemic, cases were largely back to pre-pandemic levels by the late-pandemic, with some variation by gender. Changes in testing and diagnoses varied by phase of the pandemic. Some key populations may require additional outreach efforts to attain pre-pandemic testing levels.

Identifiants

pubmed: 37206577
doi: 10.3389/frph.2023.1072700
pmc: PMC10188963
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1072700

Informations de copyright

© 2023 Pyra, Schafer, Rusie, Houlberg, Thompson and Hazra.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Sex Transm Dis. 2021 May 1;48(5):e59-e63
pubmed: 33534405
Int J Epidemiol. 2017 Feb 1;46(1):348-355
pubmed: 27283160
Sex Transm Dis. 2021 Jul 1;48(7):e91-e93
pubmed: 33783411
Sex Res Social Policy. 2021 Aug 20;:1-15
pubmed: 34457080
Sex Transm Dis. 2021 Aug 1;48(8S):S44-S49
pubmed: 33967230
J Infect Dis. 2021 Mar 29;223(6):1019-1028
pubmed: 33507308
AIDS Behav. 2022 Jul;26(7):2338-2348
pubmed: 35044555
Sex Transm Dis. 2021 Oct 1;48(10):798-804
pubmed: 34224523
J Acquir Immune Defic Syndr. 2021 May 1;87(1):639-643
pubmed: 33512848
Sex Transm Dis. 2021 Jul 1;48(7):e94-e96
pubmed: 33872225
J Infect Dis. 2021 Sep 1;224(5):798-803
pubmed: 34134130
MMWR Morb Mortal Wkly Rep. 2022 Jun 24;71(25):820-824
pubmed: 35737573
AIDS Behav. 2021 May;25(5):1361-1365
pubmed: 33599879

Auteurs

Maria Pyra (M)

Department of Data, Evaluation, & Epidemiology, Howard Brown Health, Chicago, IL, United States.
Institute for Sexual & Gender Minority Health & Wellbeing, Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.

Tommy Schafer (T)

Department of Data, Evaluation, & Epidemiology, Howard Brown Health, Chicago, IL, United States.

Laura Rusie (L)

Department of Data, Evaluation, & Epidemiology, Howard Brown Health, Chicago, IL, United States.

Magda Houlberg (M)

Department of Data, Evaluation, & Epidemiology, Howard Brown Health, Chicago, IL, United States.

Hale M Thompson (HM)

Department of Data, Evaluation, & Epidemiology, Howard Brown Health, Chicago, IL, United States.

Anu Hazra (A)

Department of Data, Evaluation, & Epidemiology, Howard Brown Health, Chicago, IL, United States.
Division of Infectious Diseases, Department of Medicine, University of Chicago, Chicago, IL, United States.

Classifications MeSH